Pharmaceutical filing citing a Journal of the American Academy of Dermatology paper — Palvella Therapeutics, 2026-08-04
Palvella TherapeuticsPalvella TherapeuticsNASDAQ PVLA
Filings SEC · Quote Google cited a paper published in the Journal of the American Academy of Dermatology as the basis for its claims in a regulatory filing submitted to the U.S. Securities and Exchange CommissionU.S. Securities and Exchange Commission
Regulator · Website. The company read the manner in which it wrote the paper and the actual scope of the paper in sequence. The stock price movement for one month after the filing was compared to past cases of the same type to determine its position. This is a retrospective judgment written after knowing the results. The paper was read only up to the abstract.
The disclosure is written in the press release as follows:
When a U.S. listed company has something to inform its shareholders, the form it files with the Securities and Exchange Commission is called 8-K. Palvella Therapeutics filed this document on 2026-08-04, with item numbers 2.02 Earnings Release · 7.01 Reg FD Disclosure · 9.01 Financial Statements and Exhibits. The company cited a paper published in Journal of the American Academy of Dermatology in the press release attached to it. If the sentence citing the paper is translated verbatim, it reads as follows.
Unless otherwise expressly stated, we obtained this industry, business information, market data, prevalence information and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources, in some cases applying our own assumptions and analysis that may, in the future, prove not to have been accurate.
What a reader should first check is where the company placed the paper within the press release. Next, the reader should determine whether the paper supports the company's entire claim or only a part of it. To answer the latter question, one must read the full paper. This article, which has only read the abstract, cannot provide an answer to that.
The scope of the paper discussed in the abstract is limited to this.
The paper's title is Penile angiokeratomas (PEAKERs) and clitoral angiokeratomas (CLANKERs) are unique variants of genital angiokeratomas and it was published in Journal of the American Academy of Dermatology on 2026-07-01. The authors are affiliated with Touro University California. The summary at the beginning of the paper is called abstract. This article has read only up to this point. The paragraph was written by a person after filtering out a draft written by a machine by comparing numbers, so it is of a different grade than a full-text reading and original judgment.
The abstract of this paper is not publicly available, so it has not been summarized. What can be understood from the title is that it is a dermatology paper discussing the characteristics of a benign lesion called vascular keratosis that occurs in the genital area. The number of people observed and the method of observation are in the main text.
What the abstract does not answer remains in the full text and appendix. This article, which has not gone beyond the abstract, leaves the blanks as they are. Readers should compare the two citations above to determine which sentence in the abstract corresponds to the citation made by the company.
One month later, the stock price was within the middle half of the sample.
The remaining return after subtracting the portion that moves with the overall market is called excess return. The date is written as trading day, counting only the days the stock market is open. In terms of the calendar, 20 trading days are approximately one month. The excess return for the day of the regulatory filing and the following month are listed in the table below.
| Period | Excess return relative to the market | Meaning |
|---|---|---|
| Five trading days before the filing | −1.4% | The extent of movement before the filing |
| On the day of the filing | +6.3% | On the filing day or the first trading day after |
| Accumulated over +1 to +5 trading days | +7.0% | One week |
| +1 to +20 trading days cumulative | +0.4% | One month |
A bundle of past cases of the same type is called a sample. The position counted from the bottom is expressed as a percentile. The one-month excess return of +0.4% in this case is within the bottom 65% of the 142 samples and is within the lower half.
| Sample scale (20 trading days) | Tenth from the bottom | Fourth from the bottom | median | top 25% | top 10% | This case |
|---|---|---|---|---|---|---|
| Excess return | −31.9% | −20.1% | −7.4% | +5.5% | +19.5% | +0.4% |
Half of the sample falls between the two marks in the middle of the table. From the table, one can check whether this case is inside or outside. The sample collects cases where U.S. listed companies wrote papers in 8-K over the past ten years. The company itself is excluded from the sample. The numbers written here are past facts, not rules to be applied to the next case.
After the regulatory filing, the company issued such documents
After the filing date, the company issued three 8-K filings, listed only by item numbers. In 8-K filings without titles, item numbers indicate the type of content. One can determine whether it was an earnings announcement or a contract based on that number. What exactly happened is read in the original text of each link.
- The 8-K could not be found in the SEC list after the filing date.
What this article does not answer
This article, which reads only abstracts, cannot answer how the paper re-examined what and to what extent. The number of citations the company's paper has received afterward can be rechecked via the OpenAlexOpenAlex
Data source · Website citation count. The next thing to look at is whether the company's next 8-K again cites the same paper.
Glossary
- 8-K
- A Form 8-K is a report that a publicly traded company in the United States files with the Securities and Exchange Commission to inform shareholders of material events. Different items are identified by item numbers, such as earnings, contracts, or executive changes. All events in this article are sourced from this document.
- Excess return
- The portion of a stock's return that remains after subtracting the overall market return. It is used to isolate the movement specific to the company, excluding the effects of broad market trends.
- Trading day
- A date that counts only the days when the stock market is open. Since weekends and holidays are excluded, 20 trading days typically span about a calendar month.
- Sample and Percentile
- A bundle of past cases of the same type is a sample, and the position from the bottom within it is expressed as a percentile. A percentile of 10 means that nine out of ten cases performed better than this case.
- Abstract
- A summary placed at the beginning of a paper. The author writes in a few sentences what was done, how it was done, and what results were obtained. Without reading the full text, one cannot know the details and limitations of the method.